Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
PHASE2
This phase II trial studies how well giving olutasidenib with azacitidine, ...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
PHASE2
This study aims to evaluate whether immediate allogeneic hematopoietic stem...